Medicine & Life Sciences
Mucopolysaccharidosis I
100%
Iduronidase
75%
Beauty
34%
Curcumin
28%
Genetic Therapy
26%
Glycosaminoglycans
24%
Enzymes
24%
GM1 Gangliosidosis
19%
Transgenes
19%
Galactosidases
18%
Craniofacial Abnormalities
18%
Enzyme Replacement Therapy
18%
Blood-Brain Barrier
18%
Mucopolysaccharidoses
17%
Deamination
16%
Nervous System Malformations
16%
Severe Combined Immunodeficiency
16%
Nanomedicine
16%
Dependovirus
15%
Investigational Therapies
15%
Gene Editing
15%
Injections
15%
Liver
14%
Adult Respiratory Distress Syndrome
13%
Tissue Plasminogen Activator
13%
Lectins
13%
Thyroid Hormones
12%
Biological Availability
12%
Drug Delivery Systems
12%
Transposases
11%
Central Nervous System
11%
Genes
11%
Transgenic Mice
11%
Fibrin
10%
Genome
10%
Neoplasms
10%
DNA
10%
Hepatocellular Carcinoma
10%
Perfusion
9%
Lung
9%
Spleen
9%
Monoclonal Antibodies
9%
Parturition
8%
Animals
8%
Silybin
8%
Clinical Trials
8%
Brain
8%
Breast Neoplasms
8%
Safety
7%
Mucopolysaccharidosis VII
7%
Chemical Compounds
Glycosaminoglycan
43%
Metabolic
33%
Curcumin
27%
Plasma
22%
Dose
21%
DNA Cytosine
21%
Chemopreventive
19%
Glutamic Acid Residue
17%
Deamination
14%
Enzyme Activity
13%
Bioavailability
13%
Single-Stranded DNA
13%
Mutation
10%
Fuel
10%
Reduction
9%
Donor
8%
Substitution Reaction
7%
Thickening
7%
Ganglioside GM3
6%
Drug
6%